- Home
- Publications
- Publication Search
- Publication Details
Title
Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 9, Pages 1277
Publisher
MDPI AG
Online
2019-08-30
DOI
10.3390/cancers11091277
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer
- (2019) Andrea Doni et al. Frontiers in Immunology
- Long pentraxin 3: A novel multifaceted player in cancer
- (2018) Arianna Giacomini et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth
- (2018) Priscila Fabiana Rodrigues et al. Frontiers in Oncology
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
- (2017) Romana-Rea Begicevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification
- (2017) Gottfrid Sjödahl et al. JOURNAL OF PATHOLOGY
- A place for precision medicine in bladder cancer: targeting the FGFRs
- (2016) Erica di Martino et al. Future Oncology
- Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors
- (2016) Riccardo Castelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Blocking the FGF/FGFR system as a two-compartment antiangiogenic/antitumor approach in cancer therapy
- (2016) Arianna Giacomini et al. PHARMACOLOGICAL RESEARCH
- Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma
- (2016) Seungtaek Lim et al. YONSEI MEDICAL JOURNAL
- Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas
- (2016) Obi L. Griffith et al. Cell Reports
- Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems
- (2015) Pontus Eriksson et al. BMC Medical Genomics
- Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy
- (2015) Roberto Ronca et al. CANCER CELL
- PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
- (2015) Eduardo Bonavita et al. CELL
- Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors
- (2015) Margarida Ferreira-Teixeira et al. Oncotarget
- A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers
- (2015) Arianna Giacomini et al. Oncotarget
- The Humoral Pattern Recognition Molecule PTX3 Is a Key Component of Innate Immunity against Urinary Tract Infection
- (2014) Sébastien Jaillon et al. IMMUNITY
- The Health Economics of Bladder Cancer: An Updated Review of the Published Literature
- (2014) Christina Yeung et al. PHARMACOECONOMICS
- Prototypic Long Pentraxin PTX3 Is Present in Breast Milk, Spreads in Tissues, and Protects Neonate Mice from Pseudomonas aeruginosa Lung Infection
- (2013) S. Jaillon et al. JOURNAL OF IMMUNOLOGY
- Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer
- (2013) Roberto Ronca et al. JOURNAL OF PATHOLOGY
- Long Pentraxin-3 Inhibits Epithelial-Mesenchymal Transition in Melanoma Cells
- (2013) R. Ronca et al. MOLECULAR CANCER THERAPEUTICS
- Normal and neoplastic urothelial stem cells: getting to the root of the problem
- (2012) Philip Levy Ho et al. Nature Reviews Urology
- A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer
- (2012) Steve Goodison et al. PLoS One
- Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors
- (2011) D. Leali et al. MOLECULAR CANCER THERAPEUTICS
- Cancer stem cells in bladder cancer: a revisited and evolving concept
- (2010) Keith Syson Chan et al. CURRENT OPINION IN UROLOGY
- Antiangiogenic Activity of a Neutralizing Human Single-Chain Antibody Fragment against Fibroblast Growth Factor Receptor 1
- (2010) R. Ronca et al. MOLECULAR CANCER THERAPEUTICS
- Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples
- (2009) Angela Bentivegna et al. CANCER SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started